Clinical trial
Patient Selection and Long-Term Outcomes of Pace & Ablate Strategy in Atrial Fibrillation
NCT07852221
Drugs and interventions used in this trial
0 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No interventions are currently published for this study in CureCurrent. View the original registry record below.
Study at a glance
Registry-backedPatient Selection and Long-Term Outcomes of Pace & Ablate Strategy in Atrial Fibrillation
Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Atrial Fibrillation (AF)unresolved
Pacing-Induced Cardiomyopathyunresolved
Heart Failureverified · MONDO: heart failure
Interventions
Sponsors & collaborators
Insel Gruppe AG, University Hospital Bernlead sponsor
University of Berncollaborator
University Hospital, Basel, Switzerlandcollaborator
University Hospital, Genevacollaborator
Silesian Centre for Heart Diseases, Zabrzecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07852221 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.